English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 12 Help

Selected(0)Clear Items/Page:    Sort:
Glucuronidation Homeostasis in Colorectal Cancer: New Mechanistic Insights into Carcinogenesis and Precision Medicine Presentation
会议地点: Macao, 会议日期: Aug 24-26, 2024, 报告日期: 2024-08-01
Authors:  YAN RU
Adobe PDF | Favorite |  | Submit date：2024/08/31
Glucuronidation Homeostasis  Colorectal Cancer  Precision Medicine  Gut Microbial Β-glucuronidases  Gus Inhibitor  
结直肠癌标志微生物β-葡萄糖醛酸苷酶及其应用 Colorectal cancer gut microbial β-Glucuronidase biomarker and application thereof Patent
专利类型: 发明专利 Invention, 专利号: N/A, 申请日期: 2024-05,
Authors:  YAN RU;  Chen, Junru
Adobe PDF | Favorite |  | Submit date：2024/08/31
Gut Microbial Β-glucuronidases  Colorectal Cancer  Biomarker  
An atlas of gut microbial β-glucuronidases and the microbiome-GUS-metabolite axis in colorectal cancer patients. Conference proceedings
Authors:  Chen, Junru;  YAN RU
Favorite |  | Submit date：2023/08/30
Gut Microbial Β-glucuronidases  Microbiome-gus-metabolite Axis  Colorectal Cancer  
Fecal microbial SN-38G metabotypes in colorectal cancer patients are associated with irinotecan-induced delayed diarrhea Conference paper
Wu, Rongrong, Chen, Junru, Jia, Yifei, Chen, Yijia, Li, Yang, YAN RU. Fecal microbial SN-38G metabotypes in colorectal cancer patients are associated with irinotecan-induced delayed diarrhea[C], 2023.
Authors:  Wu, Rongrong;  Chen, Junru;  Jia, Yifei;  Chen, Yijia;  Li, Yang; et al.
Favorite |  | Submit date：2024/08/31
Sn-38g Metabotypes  Fecal Microbial Metabolism  Colorectal Cancer  Irinotecan-induced Delayed Diarrhea  Gut Microbial Β-glucuronidases  
Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases Journal article
Wang, Panpan, Wu, Rongrong, Jia, Yifei, Tang, Puipui, Wei, Bin, Zhang, Qingwen, Wang, Vivien Ya Fan, Yan, Ru. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases[J]. International Journal of Biological Macromolecules, 2022, 220, 1532-1544.
Authors:  Wang, Panpan;  Wu, Rongrong;  Jia, Yifei;  Tang, Puipui;  Wei, Bin; et al.
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:7.7/7.7 | Submit date：2022/12/01
Allosteric Interaction  Flavones  Human Gut Microbial Β-glucuronidases  Inhibitors  Loop 1-type Guss  Structure-activity Relationship  
Inhibition and structure-activity relationship of dietary flavones against three Loop 1 human gut microbial β-glucuronidases Journal article
Wang, Panpan, Wu, Rongrong, Jia, Yifei, Tang, Puipui, Zhang, Qingwen, Wang, Yafan, Yan, Ru. Inhibition and structure-activity relationship of dietary flavones against three Loop 1 human gut microbial β-glucuronidases[J]. International Journal of Biological Macromolecules, 2022, 220, 1532-1544.
Authors:  Wang, Panpan;  Wu, Rongrong;  Jia, Yifei;  Tang, Puipui;  Zhang, Qingwen; et al.
Favorite |   IF:7.7/7.7 | Submit date：2022/08/30
Gut Microbial Metabolism  Β-glucuronidases  Gus Inhibitor  Flavones  Structure-activity Relationship  Allosteric Inhibition  
Host UDP-glucuronosyltransferases (UGTs) – gut microbial β-glucuronidases (GUSs) axis in metabolic homeostasis and drug exposure Presentation
报告日期: 2022-06-01
Authors:  Yan, Ru
Favorite |  | Submit date：2022/08/30
Gut Microbial Metabolism  Host Udp-glucuronosyltransferases  Gut Microbial Β-glucuronidases  Host Ugts – Gut Microbial Guss Axis  Metabolic Homeostasis  Drug Exposure  
Human gut bacterial β-glucuronidase inhibition: An emerging approach to manage medication therapy Journal article
Wang, Panpan, Jia, Yifei, Wu, Rongrong, Chen, Zhiqiang, Yan, Ru. Human gut bacterial β-glucuronidase inhibition: An emerging approach to manage medication therapy[J]. Biochemical Pharmacology, 2021, 190, 114566.
Authors:  Wang, Panpan;  Jia, Yifei;  Wu, Rongrong;  Chen, Zhiqiang;  Yan, Ru
Favorite | TC[WOS]:30 TC[Scopus]:41  IF:5.3/5.2 | Submit date：2021/12/08
Β-glucuronidases  Gut Microbial Metabolism  Drug Toxicity  Gus Inhibitor  Gut Microbiota  
Gut microbial beta-glucuronidases: From enterohepatic cirucation to medication modulation (肠道菌β-葡萄糖醛酸苷酶：从肠肝循环到药物治疗调控) Presentation
报告日期: 2021-04-01
Authors:  Yan, Ru
Favorite |  | Submit date：2022/08/30
Gut Microbial Metabolism  Β-glucuronidases  Enterohepatic Cirucation  Medication Modulation  
Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy Journal article
Wang, Panpan, Jia, Yifei, Wu, Rongrong, Chen, Zhiqiang, YAN RU. Human Gut Microbial β-Glucuronidase Inhibition: An Emerging Approach to Manage Medication Therapy[J]. Biochemical Pharmacology, 2021, 190, 114566.
Authors:  Wang, Panpan;  Jia, Yifei;  Wu, Rongrong;  Chen, Zhiqiang;  YAN RU
Favorite |   IF:5.3/5.2 | Submit date：2023/08/31
Gut Microbiota  Gut Microbial Β-glucuronidases  Inhibition  Medication Therapy